ConductScience.org, home

Paper41884792

Symptom relief and cytokine modulation by clarithromycin in mild COVID-19 pneumonia: an exploratory, multicenter, randomized-controlled open-label trial (CAME-COVID study).

Yamamoto K and 25 others. Ther Adv Infect Dis, 2026. Cited by 0 papers, by iCite.

Cite this record

ConductScience Library. Symptom relief and cytokine modulation by clarithromycin in mild COVID-19 pneumonia: an exploratory, multicenter, randomized-controlled open-label trial (CAME-COVID study). Papers, record 41884792. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/41884792

Download JSON
Sources
11 sources
Release
papers-2026-11-12-0.1.0

Paper

PubMed's record of the paper, with iCite's citation figures. No abstract is shown.

Title
Symptom relief and cytokine modulation by clarithromycin in mild COVID-19 pneumonia: an exploratory, multicenter, randomized-controlled open-label trial (CAME-COVID study).
PubMed
Journal
Ther Adv Infect Dis
PubMed
Year
2026
PubMed
Publication types
Journal Article
PubMed
Citations, by iCite
0
iCite
Revised in PubMed
2026-09-26
PubMed

Authors26

The authors in the order PubMed's record lists them, with the ORCID iDs it states.

OrderAuthorForenameKindORCID iD
1Yamamoto KKazuko
2Iwanaga NNaoki
3Umemura AAsuka
4Sawai TToyomitsu
5Sumiyoshi MMakoto
6Hashiguchi KKohji
7Mori YYusuke
8Ishii HHiroshi
9Futsuki YYoji
10Kiyohara MMaiko
11Ota KKenji
12Kosai KKosuke
13Sasaki DDaisuke
14Takamatsu YYuki
15Inoue SShingo
16Morita KKouichi
17Tsutsui SShin
18Ashizawa KKazuto
19Takazono TTakahirohttps://orcid.org/0000-0002-0696-5386
20Sakamoto NNoriho

Source PubMed

See all 26 authorsDownload CSV of authors

Topics0

NLM's MeSH indexing of the paper, its major topics first.

None in this release.

References48

The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.

OrderPMIDTitleJournalYearIn PapersSource
137751595Long-Term Safety Profiles of Macrolides and Tetracyclines: A Systematic Review and Meta-Analysis.J Clin Pharmacol2024https://conductscience.org/library/papers/37751595PubMed
232678530Dexamethasone in Hospitalized Patients with Covid-19.N Engl J Med2021https://conductscience.org/library/papers/32678530PubMed
336899952Pathogenesis Underlying Neurological Manifestations of Long COVID Syndrome and Potential Therapeutics.Cells2023https://conductscience.org/library/papers/36899952PubMed
438058790Post-COVID-19 pulmonary fibrosis: An ongoing concern.Ann Thorac Med2023https://conductscience.org/library/papers/38058790PubMed
537023433Outpatient treatment of COVID-19: an experience with 552 cases in Mexico.J Infect Dev Ctries2023https://conductscience.org/library/papers/37023433PubMed
639094763Impact of anti-fibrotic medications on post-COVID-19 pulmonary fibrosis: A systematic review and meta-analysis.Int J Infect Dis2024https://conductscience.org/library/papers/39094763PubMed
735223745Targeting TNF-α for COVID-19: Recent Advanced and Controversies.Front Public Health2022https://conductscience.org/library/papers/35223745PubMed
835289561Antibiotics for the Treatment of COVID-19.Am Fam Physician2022https://conductscience.org/library/papers/35289561PubMed
934643720Short-term and Long-term Rates of Postacute Sequelae of SARS-CoV-2 Infection: A Systematic Review.JAMA Netw Open2021https://conductscience.org/library/papers/34643720PubMed
1037185637Fatigue outcomes following COVID-19: a systematic review and meta-analysis.BMJ Open2023https://conductscience.org/library/papers/37185637PubMed
1138184008Clarithromycin for early anti-inflammatory responses in community-acquired pneumonia in Greece (ACCESS): a randomised, double-blind, placebo-controlled trial.Lancet Respir Med2024https://conductscience.org/library/papers/38184008PubMed
1237012080ERS/ESICM/ESCMID/ALAT guidelines for the management of severe community-acquired pneumonia.Eur Respir J2023https://conductscience.org/library/papers/37012080PubMed
1335008594COVID-19: Immunohistochemical Analysis of TGF-β Signaling Pathways in Pulmonary Fibrosis.Int J Mol Sci2021https://conductscience.org/library/papers/35008594PubMed
1434363189Early Start of Oral Clarithromycin Is Associated with Better Outcome in COVID-19 of Moderate Severity: The ACHIEVE Open-Label Single-Arm Trial.Infect Dis Ther2021https://conductscience.org/library/papers/34363189PubMed
1536477182Efficacy and Safety of Ensitrelvir in Patients With Mild-to-Moderate Coronavirus Disease 2019: The Phase 2b Part of a Randomized, Placebo-Controlled, Phase 2/3 Study.Clin Infect Dis2023https://conductscience.org/library/papers/36477182PubMed
1624585130Antibiotics for acute bronchitis.Cochrane Database Syst Rev2014https://conductscience.org/library/papers/24585130PubMed
1734249367
Early COVID-19 therapy with azithromycin plus nitazoxanide, ivermectin or hydroxychloroquine in outpatient settings significantly improved COVID-19 outcomes compared to known outcomes in untreated patients.
New Microbes New Infect2021https://conductscience.org/library/papers/34249367PubMed
1832866645Interferon gamma, TGF-β1 and RANTES expression in upper airway samples from SARS-CoV-2 infected patients.Clin Immunol2020https://conductscience.org/library/papers/32866645PubMed
1939903535A randomized, double-blind, placebo-controlled trial of IL-7 in critically ill patients with COVID-19.JCI Insight2025https://conductscience.org/library/papers/39903535PubMed
2035245942Molnupiravir and Nirmatrelvir-Ritonavir: Oral Coronavirus Disease 2019 Antiviral Drugs.Clin Infect Dis2023https://conductscience.org/library/papers/35245942PubMed

See all 48 referencesDownload CSV of references

Genes6

The genes the Gene search release ties to the paper: Swiss-Prot's references first, then PubTator's text mining.

GeneNCBI Gene IDLinked byIn GenesSource
CSF31440PubTator's text mininghttps://conductscience.org/library/genes/1440NCBI Gene
CXCL83576PubTator's text mininghttps://conductscience.org/library/genes/3576NCBI Gene
FLT3LG2323PubTator's text mininghttps://conductscience.org/library/genes/2323NCBI Gene
IFNG3458PubTator's text mininghttps://conductscience.org/library/genes/3458NCBI Gene
IL153600PubTator's text mininghttps://conductscience.org/library/genes/3600NCBI Gene
TNF7124PubTator's text mininghttps://conductscience.org/library/genes/7124NCBI Gene

Download CSV of genes

Data dates

The date of each source this release read.

PubMed
2026-11-06
PubMed
iCite
2026-11-05
iCite
PMC's ID file
2026-11-05
PMC's ID file
NIH RePORTER's grant and paper links
2026-11-01
NIH RePORTER's grant and paper links
Trials
2026-11-12
Gene search
2026-11-11
Pipelines
2026-09-18

None in this release

  • Grants
  • Trials
  • Comments and corrections
  • Cited by
  • Drugs
  • Data

Sources 11

  • ChEMBL, through Open TargetsCC BY-SA 3.0
  • ClinicalTrials.govNo license stated
  • HGNCCC0
  • iCiteCC BY 4.0
  • NCBI GenePublic domain (US government)
  • NIH RePORTER's grant and paper linksPublic domain
  • Open TargetsCC0 1.0
  • PMC's ID filePublic domain (US government)
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0
Each source's terms
  • ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • ClinicalTrials.govnone stated
  • HGNCCC0: https://www.genenames.org/about/license/
  • iCiteCC BY 4.0
  • NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
  • Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this paper from software.

The record and each of its lists are JSON, twenty rows a page. No key.

GET https://conductscience.org/api/papers/v1/41884792

GET https://conductscience.org/api/papers/v1/41884792/authors?page=2